Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $9.6400 (6.76%) ($8.9500 - $9.8100) on Thu. Mar. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.38% (three month average) | RSI | 43 | Latest Price | $9.6400(6.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -7.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(54%) ARKG(47%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -3.69% in a week (0% probabilities). VIXM(-31%) VXX(-29%) UNG(-9%) TLT(-7%) UUP(-5%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.69% (StdDev 7.38%) | Hourly BBV | 0 () | Intraday Trend | 5.4% | | | |
|
5 Day Moving Average | $8.8(9.55%) | 10 Day Moving Average | $7.9(22.03%) | 20 Day Moving Average | $9.63(0.1%) | To recent high | -45.8% | To recent low | 69.4% | Market Cap | $716m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |